Profile
Michel Gardet is currently a Director at Phagenesis Ltd.
He was formerly a Director at Glycom A and Global Head-Business Operations at Nestle Health Science SA.
Michel Gardet active positions
Companies | Position | Start |
---|---|---|
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | - |
Former positions of Michel Gardet
Companies | Position | End |
---|---|---|
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Chief Operating Officer | - |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Health Technology |
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Michel Gardet